SCHEMBL7046152

SCHEMBL7046152

CC=Cc1cc(OCc2ccccc2)ccc1O

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAOB P27338 15/20 0.56
MAOA P21397 1/20 0.53
ALOX5 P09917 1/20 0.53
CYP1A2 P05177 2/20 0.51
LMNA P02545 1/20 0.51
PTGS1 P23219 1/20 0.51
SLC6A2 P23975 1/20 0.51
CYP2C19 P33261 1/20 0.51
PTGS2 P35354 1/20 0.51
SLC6A3 Q01959 1/20 0.51
HIF1A Q16665 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
LCK P06239 1/20 0.48
MCL1 Q07820 1/20 0.47
CYP1A1 P04798 1/20 0.47
CYP19A1 P11511 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7046146 1.00 MAOB (0.56) MAOBMAOAALOX5CYP1A2LMNA
SCHEMBL27685290 0.88 MAOB (0.59) MAOBMAOAALOX5CYP1A2LMNA
SCHEMBL344390 0.83 ALDH1A1 (0.63) MAOBMAOAALOX5MCL1
SCHEMBL344391 0.83 ALDH1A1 (0.63) MAOBMAOAALOX5MCL1
SCHEMBL28793395 0.82 MAOB (0.60) MAOBCYP1A2LMNAPTGS1PTGS2
SCHEMBL3621341 0.82 MAOB (0.56) MAOBMAOAALOX5CYP1A2LMNA
SCHEMBL5099007 0.82 MAOB (0.56) MAOBMAOAALOX5CYP1A2LMNA
SCHEMBL29901179 0.82 MAOB (0.56) MAOBMAOAALOX5CYP1A2LMNA
SCHEMBL9748640 0.80 ABCG2 (0.62) MAOBLMNAPTGS1PTGS2
SCHEMBL9748635 0.80 ABCG2 (0.62) MAOBLMNAPTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed